Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Yield10 advances in omega-3 fatty acid production

EditorEmilio Ghigini
Published 22/03/2024, 12:11 am
© Reuters.

WOBURN, Mass. - Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, has reached a pivotal regulatory milestone with its genetically engineered Camelina plants, which are designed to produce omega-3 fatty acids. The U.S. Department of Agriculture's Animal and Plant Health Inspection Service (USDA-APHIS) has determined that these plants do not pose an increased plant pest risk and are therefore not subject to certain federal regulations.

This decision enables Yield10 to proceed with the commercial scale planting of its modified Camelina varieties in the United States. These plants are expected to provide a stable source of omega-3 oils, which are in high demand for use in aquafeed, human nutrition, and other markets. Currently, most omega-3 fatty acids are derived from ocean-caught fish, but supply limitations and volatility have driven the search for alternative sources.

Yield10's Chief Science Officer, Dr. Kristi Snell, stated that the company plans to build seed inventory in 2024 in preparation for commercial planting and to engage with potential partners for the sale of omega-3 oil and meal. The company's submissions and the USDA-APHIS responses are publicly available on the USDA's website.

The company has previously collaborated with Rothamsted Research and signed a Letter of Intent with BioMar Group, a global aquafeed producer, to commercialize Camelina crops enriched with omega-3 fatty acids equivalent to fish oil. Yield10 is also developing second-generation Camelina lines with herbicide tolerance traits to facilitate large-scale commercial planting.

Yield10's work aligns with the SECURE Rule, enacted on May 18, 2020, which streamlines the regulatory process for genetically engineered organisms that are unlikely to pose plant pest risks. The company's Camelina plants containing omega-3 traits will still be subject to regulations by the U.S. Food and Drug Administration.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This advancement is based on a press release statement from Yield10 Bioscience. The company's goal is to establish Camelina as a platform crop for the production of sustainable seed products, including oils for renewable diesel, sustainable aviation biofuels, and omega-3 oils for various applications. Yield10 is headquartered in Woburn, MA, with a subsidiary in Saskatoon, Canada.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.